Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Atyr Pharma Inc’s stock clocked out at $3.27, up 9.00% from its previous closing price of $3.00. In other words, the price has increased by $9.00 from its previous closing price. On the day, 1.52 million shares were traded.
Ratios:
To gain a deeper understanding of ATYR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.79 and its Current Ratio is at 7.79. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 18, 2025, initiated with a Outperform rating and assigned the stock a target price of $16.
On October 04, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $17.Wells Fargo initiated its Overweight rating on October 04, 2024, with a $17 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when Gross Jane A bought 3,750 shares for $4.00 per share. The transaction valued at 15,000 led to the insider holds 9,750 shares of the business.
Broadfoot Jill Marie sold 1,254 shares of ATYR for $4,740 on Feb 04 ’25. The Chief Financial Officer now owns 31,763 shares after completing the transaction at $3.78 per share. On Feb 04 ’25, another insider, DENYES NANCY, who serves as the General Counsel of the company, sold 899 shares for $3.78 each. As a result, the insider received 3,398 and left with 26,555 shares of the company.
Stock Price History:
Over the past 52 weeks, ATYR has reached a high of $4.66, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is -0.41%, while the 200-Day Moving Average is calculated to be 9.71%.
Shares Statistics:
A total of 89.00M shares are outstanding, with a floating share count of 86.06M. Insiders hold about 3.22% of the company’s shares, while institutions hold 70.08% stake in the company.
